NCT02312661View on ClinicalTrials.gov

Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 5, 2015

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Epithelial Ovarian Cancer
Interventions
DRUG

Metformin

Metformin in increasing doses will be added to carboplatin/paclitaxel chemotherapy

DRUG

Carboplatin

Intravenous carboplatin chemotherapy in three-weekly cycles, for a maximum of 6 cycles

DRUG

Paclitaxel

Intravenous paclitaxel chemotherapy in three-weekly cycles, for a maximum of 6 cycles

Trial Locations (1)

9713 GZ

University Mecdical Center Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT02312661 - Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer | Biotech Hunter | Biotech Hunter